Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
ConclusionsAlthough the efficacy of PrEP with hydroxychloroquine for preventing COVID-19 could not be evaluated, our study showed that PrEP with hydroxychloroquine at low doses is safe.Trial registrationClinicalTrials.govNCT04331834. Registered on April 2, 2020. (Source: Trials)
Source: Trials - November 15, 2021 Category: Research Source Type: clinical trials

HCQ for Non Europeans With Mild to Severe UC
Condition:   Ulcerative Colitis (Disorder) Interventions:   Drug: Hydroxychloroquine;   Drug: Mesalamine Sponsors:   Icahn School of Medicine at Mount Sinai;   Crohn's and Colitis Foundation Not yet recruiting (Source:
Source: - November 12, 2021 Category: Research Source Type: clinical trials